Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Location: Dallas TX, Durham NC, New York NY, Palo Alto CA,
Sponsor: Stanford University
Sex: All
Age: 0 - 16
Code: NCT06080074
Phase 2, Recruiting
Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia
for
Achondroplasia
Location: Dallas TX, San Antonio TX, Houston TX, Chicago IL,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 2 - 17
Code: NCT07441876
Phase 2, Phase 3, Recruiting
MASA Valve Early Feasibility Study
for
Tetrology of Fallot, Pulmonary Stenosis, Truncus Arteriosus,
Location: Dallas TX, Peoria IL, Cincinnati OH, Philadelphia PA,
Sponsor: PECA Labs
Sex: All
Age: 0 - 22
Code: NCT05452720
Recruiting
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
for
Deep Venous Thrombosis
Location: Dallas TX, Oklahoma City OK, Austin TX, Little Rock AR,
Sponsor: Yale University
Sex: All
Age: 0 - 17
Code: NCT04924322
Phase 2, Phase 3, Recruiting
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
for
Hemophilia B
Location: Dallas TX, Houston TX, New Orleans LA, Aurora CO,
Sponsor: Regeneron Pharmaceuticals
Sex: Male
Age: 2+
Code: NCT06379789
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy